A

Apaxen

4 employees

Apaxen develops treatment for chronic NLRP3 inflammasome activation and macrophage migration inhibitory factor.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Wellness
Product Research

Date founded

2018

FAQ